Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome. Graeme L Fraser et al

18/08/2021,
Serge Rozenberg

Next meeting

11/03/2023
Cognitive disorders, depression and work ability at the menopause.

Latest news

06/01/2023
Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative (WHI) hormone therapy trials